Patent Amendment (Human Genes and Biological Materials) Bill 2010

8.45am – 9.45am

AusBiotech Ltd (Submission 97)
Dr Anna Lavelle, Chief Executive Officer
Croplife Australia (Submission 65)
Mr Matthew Cossey, Chief Executive Officer
Mr Daniel Quinn, Policy Manager - Biotechnology, Policy Manager - Minor Use

9.45am – 10.45am

Dr Luigi Palombi (Submission 103)

10.45am – 11.00am

Break

11.00am – 11.30am

Professor Andrew Christie (Submission 19) (via teleconference)

11.30am – 1.00pm

Department of Innovation, Industry, Science and Research and IP Australia (Submission 94)
Dr Kirrily Peters, Manager, Pharmaceuticals Industry Strategy & Environment Section, Department of Innovation, Industry, Science and Research
Mr Peter Lunn, Manager, Pharmaceuticals & Health Technologies Section, Department of Innovation, Industry, Science and Research
Ms Fatima Beattie, Deputy Director General, IP Australia
Ms Terry Moore, Director, Domestic Policy, IP Australia
Ms Lexie Press, Senior Examiner of Patents, IP Australia
Department of Health and Ageing (Submission 68)
Ms Jane Halton, Secretary
Ms Megan Morris, Deputy Secretary
Ms Mary McDonald, First Assistant Secretary, Regulatory Policy and Governance Division
Mr Chris Reid, General Counsel
Associate Professor Rosemary Knight, Principal Adviser, Mental Health and Chronic Disease Division